
BridgeBio Pharma Inc (NASDAQ: BBIO) – Analysts’ Revisions Show An Improving Sentiment
BridgeBio Pharma Inc (NASDAQ:BBIO) traded at $33.37 at last check on current trade day and made a downward move of -6.47% on its previous day’s price. BridgeBio Pharma Inc has a market cap of $6.34 billion and is expected to release its quarterly earnings report